Exercise training (ET) in adult and elderly patients receiving anti-lymphoma treatments is feasible and may improve the provision of care

Maria Christina Cox,Sveva Maria Nusca,Francesca Di Landro,Gabriella Marsilli,Giulia Stella,Matilde Sigona,Federica Ponzelli,Jasmine Passerini Desideri,Francesca Di Gregorio,Flavia Santoboni,Mario Vetrano,Donatella Trischitta,Renato Manno,Maria Chiara Vulpiani
DOI: https://doi.org/10.1080/10428194.2020.1842396
2020-11-24
Abstract:<span>Lymphoma treatments can produce adverse effects leading to a reduced quality-of-life (QoL). Besides, in patients ≥65years, it can promote an accelerated geriatric decay. We conducted a prospective study on supervised Exercise-Training (ET), in consecutive, patients aged 18–80years, during anti-lymphoma treatments.16/30 (53%), median-age = 65.5y, participated to the ET sessions, this was the Interventional Group (IG); 14/30 (47%), median-age = 63y, were the Reference Group (RG). Both groups participated to the fitness and the QoL assessments, at baseline (T0), 3-months (T1) and 6-months (T2) after the start of chemotherapy. The adherence to the ET program was 50% (95% CI:36–64%). The IG showed substantial improvements compared to the CG in cardiorespiratory fitness (Cooper test) at both T1 and T2 and in all the functional domain of the QoL questionnaire (QLQ-C30) at T2. This study showed ET, during chemotherapy, is feasible and safe, even in patients ≥65 years. Furthermore, it may improve the provision of care.</span>
oncology,hematology
What problem does this paper attempt to address?